Thrombolysis for ischaemic stroke despite direct oral anticoagulation
Intravenous thrombolysis is not recommended in anticoagulated patients receiving direct oral anticoagulants (DOACs) and a recent intake within the last 48 hours in US and European guidelines. However, three observational studies now suggest safety of thrombolysis in patients with recent intake of DO...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 31, 2024
|
| In: |
Stroke and vascular neurology
Year: 2024, Pages: 1-3 |
| ISSN: | 2059-8696 |
| DOI: | 10.1136/svn-2023-002727 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1136/svn-2023-002727 Verlag, kostenfrei, Volltext: https://svn.bmj.com/content/early/2024/01/30/svn-2023-002727 
|
| Verfasserangaben: | Jan C. Purrucker, Thomas R. Meinel, Duncan Wilson, Ying Xian, Teddy Y. Wu, David J. Seiffge |
| Zusammenfassung: | Intravenous thrombolysis is not recommended in anticoagulated patients receiving direct oral anticoagulants (DOACs) and a recent intake within the last 48 hours in US and European guidelines. However, three observational studies now suggest safety of thrombolysis in patients with recent intake of DOACs, and thus support previous experimental data. In this perspective, the current evidence and practical consequences are discussed. |
|---|---|
| Beschreibung: | Gesehen am 17.06.2024 |
| Beschreibung: | Online Resource |
| ISSN: | 2059-8696 |
| DOI: | 10.1136/svn-2023-002727 |